Assembly Biosciences (NASDAQ: ASMB) reported Q2 EPS of ($0.20), $0.53 better than the analyst estimate of ($0.73). Revenue for the quarter came in at $13.37 million versus the consensus estimate of $8.6 million.

For earnings history and earnings-related data on Assembly Biosciences (ASMB) click here.